Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|August 2, 2011
Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?Jeroen N Stoop, John H Robinson, Catharien M U Hilkens
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody productionBi-Sheng Liu, Jeroen N Stoop, Tom W Huizinga, et al.
Journal of Virology|October 15, 2003
Coronaviruses as vectors: position dependence of foreign gene expressionCornelis A M de Haan, Linda van Genne, Jeroen N Stoop, et al.
Virology|December 23, 2006
Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis BJeroen N Stoop, Renate G van der Molen, Ernst J Kuipers, et al.
European Journal of Immunology|October 15, 2013
Activation of human basophils by combined toll-like receptor- and FcεRI-triggering can promote Th2 skewing of naive T helper cellsJolien Suurmond, Jeroen N Stoop, Felice Rivellese, et al.
Arthritis and Rheumatism|September 24, 2010
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responsesJeroen N Stoop, Rachel A Harry, Alexei von Delwig, et al.
European Journal of Immunology|November 22, 2012
DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCsHanane el Bannoudi, Wanda G H Han, Jeroen N Stoop, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune responseJeroen N Stoop, Andrea M Woltman, Paula J Biesta, et al.
Pageof 3